Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities
NCT00403455Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2006
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Oct 2006; status: completed.
02
Drugs
paroxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00403455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403455.